3 Tesla MRI in Patients With Bladder Cancer

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

RATIONALE: New diagnostic procedures, such as 3 Tesla magnetic resonance imaging (MRI), may help find bladder cancer and learn the extent of disease.

PURPOSE: This clinical trial is studying how well 3 Tesla MRI works in finding cancer in patients with bladder cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ohio State University Comprehensive Cancer Center

Criteria

Inclusion Criteria:

• Known bladder cancer

• Scheduled for radical cystectomy and lymph node dissection.

• Able and willing to give valid written informed consent.

• No contraindications to the MRI(magnetic resonance imaging).

Exclusion Criteria:

• Not pregnant, planning to become pregnant during the study, or nursing.

• No allergy to contrast agents.

• Patient with significant renal insufficiency, i.e. an estimated glomerular filtration rate(eGRF) less than 30 mL/min/1.73m2.

• Any condition conflict based on the investigation's clinical judgment that would prevent the patient from completion all trial assessments and visits.

• Inability or unwillingness to cooperate with requirements of this trial.

• Patients who exhibit noticeable anxiety and/or claustrophobia or who exhibit severe vertigo when they are moved into the MR.

• Patients with sickle cell anemia and other hemolytic anemia.